Rochester, MN, USA, November 27, 2016 - Resoundant, Inc., the developers or Magnetic Resonance Elastography (MRE), are pleased to introduce clinical research of MRE for the brain at the Radiological Society of North America (RSNA) Annual Meeting at McCormick Place, Chicago, November 27 to December 2. "Although MRE for liver applications will continue to be Resoundant's main focus, the clinical research being conducted on brain MRE is very compelling," said Troy Ziegler, Chief Operating Officer at Resoundant. For assessing intracranial tumor stiffness, particularly meningiomas, pituitary adenomas, and vestibular schwannomas, MRE research is showing considerable clinical value in discriminatin
Journey to Growth (http://www.j2gmn.com), Rochester Area Economic Development, Inc. - RAEDI (www.raedi.com) and 504 Corporation (www.504corporation.com) will be recognizing a number of Rochester-area entrepreneurs, including Resoundant CEO, Richard L. Ehman, MD, at the 3rd Annual RAVE Event (Recognizing Awarding Valuing Entrepreneurs) on Friday, November 18th from 4:00 p.m. – 6:00 p.m. at DoubleTree in Rochester. “Entrepreneurial activity in our region continues to gain momentum. As our ecosystem continues to evolve with new programs and resources, we can expect significant economic activity to be generated as well,” said Gary Smith, RAEDI President. He continues, “RAVE is our annual opport
For the fourth year, Resoundant, Inc. will be exhibiting at the annual meeting of the American Association for the Study of Liver Diseases (AASLD), also known as The Liver Meeting®, being held on November 11 — 15, 2016, at the John B. Hynes Veterans Memorial Convention Center, Boston. "We truly appreciate the outstanding work of the AASLD, and look forward to returning to The Liver Meeting® this November," said Richard L. Ehman, MD, CEO of Resoundant, Inc. "For us, this meeting is a wonderful opportunity to learn directly from leading Hepatologists about how we can better serve both them and their patients. The field of Hepatology is moving at a rapid pace, with clinicians leveraging huge a
